← Back
$ELTX All transactions

Elicio Therapeutics, Inc.

A

$ Value

$0

Shares

73,600

Price

$0

Filed

Feb 3

Insider

Name

Connelly Robert

Title

CEO, President and Director

CIK

0001796436

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-02

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

120,570

Footnotes

Represents restricted stock units ("RSUs") that will vest as to 25% of the RSUs on February 2, 2027, the first anniversary of the grant date, with the remaining RSUs vesting in annual installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Each RSU represents the right to receive one share of common stock, par value $0.01 per share, of the Issuer. | The stock option vests and becomes exercisable as to 25% of the options on February 2, 2027, the first anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.

Filing Info

Accession No.

0001601485-26-000010

Form Type

4

Issuer CIK

0001601485

Connelly Robert's History

Date Ticker Type Value
2026-02-02 ELTX A $0
2026-02-02 ELTX A $0

Other Insiders at ELTX (90d)

Insider Bought Sold Last
Haqq Christopher
See Remarks
2026-02-02
Shah Preetam
See Remarks
2026-02-02
Connelly Robert
CEO, President and Director
2026-02-02
DeMuth Peter
Chief Scientific Officer
2026-02-02